Successful Treatment of Pure Myopathy, Associated with Complex I Deficiency, with Riboflavin and Carnitine
Overview
Affiliations
We describe a 6-year-old boy who presented with progressive muscle weakness. Additional investigations revealed the existence of a myopathy and a pure motor neuropathy. Biochemical studies in muscle tissue showed a defect of NADH dehydrogenase (complex I). The patient dramatically improved on treatment with riboflavin and L-carnitine. Seven months after the start of the treatment, complex I activity was determined again and appeared to be normalized. Normalization of the enzymatic defect at this level has not been reported before. We provide a survey of nine patients with pure myopathy, associated with complex I deficiency and onset of symptoms in childhood.
The Ubiquinone-Ubiquinol Redox Cycle and Its Clinical Consequences: An Overview.
Mantle D, Dewsbury M, Hargreaves I Int J Mol Sci. 2024; 25(12).
PMID: 38928470 PMC: 11203502. DOI: 10.3390/ijms25126765.
An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.
Marra F, Lunetti P, Curcio R, Lasorsa F, Capobianco L, Porcelli V Biomolecules. 2021; 11(11).
PMID: 34827632 PMC: 8615828. DOI: 10.3390/biom11111633.
Current and Emerging Clinical Treatment in Mitochondrial Disease.
Tinker R, Lim A, Stefanetti R, McFarland R Mol Diagn Ther. 2021; 25(2):181-206.
PMID: 33646563 PMC: 7919238. DOI: 10.1007/s40291-020-00510-6.
Panetta J, Smith L, Boneh A J Inherit Metab Dis. 2004; 27(4):487-98.
PMID: 15303006 DOI: 10.1023/B:BOLI.0000037354.66587.38.
Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease.
Artuch R, Vilaseca M, Pineda M J Inherit Metab Dis. 1998; 21(8):837-45.
PMID: 9870209 DOI: 10.1023/a:1005470702369.